TerminatedNCT00194064
Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine
Researchers are studying Olanzapine to find out how it affects manic symptoms in people with bipolarity during a manic episode.
Medication studyAges 18–70United States
Understand this study
What is this study about?
Researchers are studying Olanzapine to find out how it affects manic symptoms in people with bipolarity during a manic episode.
Who could participate?
Listed age limits: 18 years to 70 years.
- Listed locations
- ClevelandSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2002
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 18
- Sponsor
- University Hospitals Cleveland Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00194064
- Official title
Show the full official title
Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine Monotherapy in Treatment Refractory Bipolar Disorder Mania
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cleveland
Interested in joining this study?
Questions about this study
What is this study about?
Researchers are studying Olanzapine to find out how it affects manic symptoms in people with bipolarity during a manic episode.
Who is behind this study?
The study sponsor is University Hospitals Cleveland Medical Center, a university.
Does this study involve medication?
Yes. The study involves medication, including Olanzapine.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Depression in bipolarity
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolarity type I.